Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past?

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The Centers for Medicare and Medicaid Services will cut short a big experiment to try and change the way dialysis is done in ...

The early stages of chronic kidney disease (CKD) are usually asymptomatic, with kidney function progressively and ...

Kidney diseases are increasingly common, affecting millions, with many unaware of their condition. About 40% of people with ...

PKD is mainly caused by mutations in the PKD1 and PKD2 genes, affecting polycystin proteins. Disrupted signaling pathways, like cAMP and vasopressin, are major drivers of cyst growth. Tolvaptan is ...

In a rapidly heating market, Otsuka is the first to secure FDA clearance for an "anti-APRIL" therapy targeting IgA ...

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...

Polycystic kidney disease (PKD) causes round, fluid-filled sacs called cysts to grow in your kidneys. These cysts can cause your kidneys to enlarge and function poorly. People with PKD can also ...

The intersection of climate change with chronic disease and healthcare infrastructure creates a critical and underreported ...